Phase I single-dose trial of TRV 1200274 in volunteers.

Trial Profile

Phase I single-dose trial of TRV 1200274 in volunteers.

Phase of Trial: Phase I

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs TRV 027 (Primary)
  • Indications Decompensated heart failure
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 11 Sep 2012 Results were presented at the 16th Annual Meeting of the Heart Failure Society of America.
    • 20 Apr 2010 New trial record
    • 15 Apr 2010 Status changed from not yet recruiting to recruiting, according to a Trevena media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top